establishing now in Ukraine. Methods: We performed a retrospective analysis of the real data from 450 medical records of patients who were treated in a Lviv Regional Perinatal Center in 2013. The results of our previous study of treatment cost of endometriosis in Ukraine were used (Zalis'ka O., Piniazhko O. et al. 2014) . We used the prices from Ukrainian database of Morion company (Kiev) on 01.06.2014 (1 EUR = 16,04 UAH). Results: According to the analysis 70% of women with endometriosis choose treatment hormones with the duration of six month usually and 30% of patients undergo surgical treatment. Annual direct cost of endometriosis per patient varies from € 224 to € 487 depending on the chosen scheme of pharmacotherapy, which differences 2 times. Accordingly, costs correlated with clinical severity and patient's financial position and ability to pay. Based on the data of State Statistics Service of Ukraine, we estimated that the number of women of reproductive age in Ukraine was 14,7 million in 2013. Therefore when to extrapolate data the number of women with endometriosis could amount approximately 1,47 million and 1,03 million women would take pharmacotherapy instead of surgery. The annual cost of treatment hormones of endometriosis could amount from € 230,5 million to € 501,6 million. ConClusions: The economic burden of endometriosis in Ukraine demonstrates a significant need in the optimization of the management of this disease within the introduction of health insurance system and health technology assessment of the applicable hormones.
PIH18 Burden and Cost of MultIPle CHronIC dIseases In a large CoHort of elderly In Italy
Rossi E. , Cinconze E. , De Rosa M. CINECA Interuniversity Consortium, Casalecchio di Reno, Italy objeCtives: Life expectancy in Italy is constantly increasing (+2,4 years for men and +1,7 years for women from 2001 to 2011) with a consequent effect on health needs and expenditure. Furthermore, on overall population, 21% has one chronic disease, 9,3% two and 8% more than three. The aim of this study is to evaluate the burden of multiple chronic diseases and associated costs in a large community setting of Italian elderly population, starting from Cineca ARNO Observatory. Methods: ARNO Observatory is a comprehensive population-based database which integrates since 1987 administrative data from Local Health Units to monitor health data in the real world. On a population of 10,5 millions of inhabitants we selected a cohort of 2.166.000 (21%) subjects over 65 years. Outpatient drug prescriptions, inpatient hospital discharges, diagnostic, lab tests prescriptions were analyzed during 2012 to evaluate chronic diseases, multiple chronic conditions and illness direct costs. Results: From selected cohort, 82,5% has at least one chronic disease and this proportion rises up to 89,6% in over 80s. Hypertension is the most common disease (67%), followed by dyslipidemia (30%) and diabetes (18%). Over 50% of elderly has multiple chronic diseases but the risk of developing concomitant chronic illnesses rises with ages (60% of people aged > = 85 have comorbidities). Integration of administrative data led to the evaluation of cost of illness which varies from 2.528€ for hypertension to 13.613€ for Acute Coronary Syndrome; the average cost of patients with 2 or more comorbidities is twice than patients with only one chronic disease. In general, more than a half of cost is due to hospitalization (57%), 27% to drugs and 16% to diagnostic exams (16%). ConClusions: Analyses of real world data represent an effective tool for the evaluation of elderly population diseases and can be a valid instrument to support clinical governance.
PIH19 ePIdeMIologICal and fInanCIal Burden of PreterM laBor HosPItalIzatIons -an analysIs of gerMan ClaIMs data
objeCtives: Preterm Labor (PTL) in pregnant women is a common obstetrics inpatient diagnosis. It is important to differentiate between threatened PTL associated with potentially avoidable hospitalization and PTL resulting in a preterm birth (PTB) with respect to their burden to the health care system. The prevention and diagnostic-driven reduction of such hospital admissions for observational reasons are supposed to reduce costs. The aim is to analyze the epidemiological and financial impact of programs to prevent avoidable hospital admissions due to threatened PTL. Methods: A cohort of singletons at the University hospital Greifswald with PTL-related hospital admissions prior to birth was analyzed with respect to resource use and obstetrics outcomes. This bottom-up analysis was conducted from the perspective of the statutory health care system based on accounting information claims from the hospital`s database for the period 2007 to 2012. ICD-10 codes were used to identify the study population. All costs were inflated to 2012 using the German GDP index. Results: Out of 4,408 singleton births, potentially avoidable hospital admissions were found in 248 cases (5.6 %). In this subgroup, 17 infants were delivered preterm (avg. 34.8 weeks), resulting in a PTB rate of 6.9 % compared to a general rate of 8.7 % in Germany. These hospitalizations led to average costs of about 1,600 EUR per case (min. 300 EUR; max. 5,600 EUR). ConClusions: Although threatened PTL affects one singleton pregnancy in 20, the fraction of costs resulting from observational admissions associated with threatened PTL is less than 0.7 percent compared to the total department costs. This finding conflicts with the cost-saving potential of prevention programs (e. g. pH self-assessment) suggested in the literature. between 2001 and 2012. One study was on early screening using maternal markers, and concluded that this may be cost-effective from a payer perspective. Three other studies focused on treatment and management, and concluded that induction of delivery is the most cost-effective option in term preeclampsia. Also, magnesium sulphate was found to be a cost-effective treatment, but more so in low income countries. One study was a comprehensive HTA report on combination strategies of screening and prevention, which found that providing calcium to all pregnant women without prior testing was the most cost-effective strategy. The BIA, on introducing a novel diagnostic test, concluded that the savings associated with this test would offset its initial cost. ConClusions: Novel biomarkers in screening for and diagnosing preeclampsia show promise as a cost-effective approach, from a payer perspective. Moreover, magnesium sulphate seemed to be a cost-effective option to manage seizures in preeclamptic women while delivery remains the ultimate efficient treatment, especially for women with term preeclampsia.
PIH20 InCIdenCe and long-terM Cost of oral steroId-related adverse events In CHronIC dIseases In Poland

PIH15 PrICe varIatIon In oBstetrICal servICes In a rural state
Erten M. Z. , Phillips J. , Jones C. , Kappel S. , Meyer M.
University of Vermont -College of Medicine, Burlington, VT, USA
objeCtives: To determine and quantify the level of price variation in inpatient care for obstetrical services across hospitals in the State of Vermont, USA. Methods: We used data from Vermont Healthcare Claims Uniform Reporting and Evaluation System (VHCURES) for the calendar year 2012. We generated single-line summaries for all inpatient obstetrical services with an admission date in 2012. We excluded records for Medicaid, secondary payments either to Medicare or another commercial insurance, denied claims, non-VT resident claims and adjustments to existing claims. This produced a total of 4,019 records for the evaluated services from 13 Vermont hospitals. We calculated the allowed amount for each Diagnosis Related Group (DRG) (total amount a hospital received from a payer, including any prepaid amounts related to the service, plus the amount due from a patient through copayment, co-insurance and deductible). The outcome of interest is the average price of a specific DRG at each hospital as a percent of group average price in Vermont Hospitals. To reflect patient severity we adjusted prices by case-mix. Results were generated for hospitals only when there were at least 10 discharges in a specific hospital. Results: The average prices for a vaginal delivery with complicating diagnoses varied between 66% to 156% of the group average, vaginal delivery without complicating diagnoses varied between 74% to 182%, neonate with other significant problems varied between 60% to 206% and normal newborn varied between 77% to 180%. ConClusions: There is wide variation in payments for obstetrical services across Vermont hospitals. Further analysis is necessary to understand the role of various factors that contribute to this variation. During this transition period to a single-payer system in the rural state of Vermont, policy makers will need evidencebased information to ensure undiminished access to care in obstetrical services. Albacete, Spain, 3 Nestlé Health Science, Barcelona, Spain, 4 Outcomes 10, Castellon, Spain objeCtives: To estimate the economic impact of malnutrition on annual direct cost in Spanish institutionalized or community-dwelling older adults. Methods: A systematic review was carried out on the economic burden and use of medical resources associated with malnutrition in institutionalized or communitydwelling older adults. National and international databases until December 2013 were searched. Based on results from the literature review, an Excel-based tool was developed to estimate the annual cost difference between malnourished and well-nourished institutionalized and community-dwelling older adults in Spain. Malnutrition prevalence, annual frequency of general practitioner (GP) visits and hospitalizations were the main inputs considered in the model. Unit costs were derived from health care cost databases available in Spain (Euros, 2014). One-way sensitivity analysis (OWSA) was performed. Results: The results of the systematic review showed that malnutrition implies higher medical costs in the study population, particularly due to the length of hospital stay, number of hospital admissions and GP visits. Economic results showed that the annual cost associated with the use of resources of a malnourished patient (€ 5,000.66) was 3.5 times higher than that of a well-nourished (€ 1,433.78). OWSA showed that prevalence of malnutrition was the variable with the greatest impact on results. Decreasing the prevalence of malnutrition according to minimum values identified in the literature (from 15.6% and 4.4%, to 2% and 3% in institutionalized and community-dwelling patients respectively), caused the annual cost per patient with malnutrition to drop from € 5,000.66 to € 2,511.83, while increasing it to the maximum values (62% and 23%, respectively), implied a rise from € 5,000.66 to € 24,291.93 in the annual cost per patient. ConClusions: Adopting measures to reduce the prevalence of malnutrition in institutionalized or community-dwelling older adults would reduce by up to 50% the annual cost per patient associated to GP visits and hospitalizations. objeCtives: Endometriosis affects 10% of women of reproductive age and WERF EndoCost study has recently shown that it imposes substantial economic burden on society through the reduced economic and personal productivity. The aim of the study was to estimate the prevalence of endometriosis and the cost of illness from the payer's perspective in Ukraine as the model of health insurance is
PIH16
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